COVID-19 and the ERS International Congress 2020
https://www.youtube.com/watch?v=2JZr-xXVfNA ERS International Congress 2020 update - A message from ERS President, Prof. Thierry Troosters
Defining high probability when making a diagnosis of asthma in primary care: mixed-methods consensus workshop
Respiratory medicine – Original research BMJ Open 2020;10:e034559. doi: 10.1136/bmjopen-2019-034559 Luke Daines, Steff Lewis, Antonius Schneider, Aziz Sheikh, Hilary Pinnock Abstract Objective Making the diagnosis of asthma is challenging. Guidelines recommend that clinicians identify a…
COVID-19 vs H1N1 Influenza: A Clinical Characteristic Comparison
Bryant Moeller Hospitalized patients with coronavirus disease 2019 (COVID-19) exhibited higher proportions of nonproductive cough, fatigue, and gastrointestinal symptoms as well as lower severity of illness scores than patients with…
Different expression levels of interleukin-35 in asthma phenotypes
Research – Open Access Wei Li, Ruihan Gao, Tong Xin & Peng Gao Respiratory Research volume 21, Article number: 89 (2020) Abstract Background Interleukin (IL)-35 is a newly discovered inhibitory cytokine which is produced by regulatory B…
Comorbidity, Age, and Time to Treatment Linked to COVID-19 Progression
HealthDay News — Factors associated with coronavirus disease 2019 (COVID-19) progression include comorbidity, age, and time from illness onset to antiviral treatment, according to a study published online March 27…
Fractional Exhaled Nitric Oxide (FENO) in the Management of Asthma: A Position Paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
Enrico Heffler, Giovanna Elisiana Carpagnano, Elisabetta Favero, Giuseppe Guida, Mauro Maniscalco, Andrea Motta, Giovanni Paoletti , Giovanni Rolla, Eugenio Baraldi, Vincenza Pezzella, Giorgio Piacentini, Stefano Nardini. Abstract Asthma prevalence in…
Validation of the portable Bluetooth® Air Next spirometer in patients with different respiratory diseases
Research – Open Access Konstantinos P. Exarchos, Athena Gogali, Agni Sioutkou, Christos Chronis, Sofia Peristeri & Konstantinos Kostikas Respiratory Research volume 21, Article number: 79 (2020) Cite this article Abstract Background Chronic respiratory diseases constitute a considerable part in the practice of…
FDA Strengthens Warning About Risk of Neuropsychiatric Events With Montelukast
Diana Ernst, RPh The Food and Drug Administration (FDA) is requiring the addition of a Boxed Warning to the prescribing information for montelukast, following a review of study data and case reports…
Risk of wheezing and asthma exacerbation in children treated with paracetamol versus ibuprofen: a systematic review and meta-analysis of randomised controlled trials
Research article – Open Access Mohamed Sherbash, Luis Furuya-Kanamori, Joanne Daghfal Nader & Lukman Thalib BMC Pulmonary Medicine volume 20, Article number: 72 (2020) Abstract Background Paracetamol and ibuprofen are the most commonly used medications for fever and pain…
Shared Decision Making for Better Asthma Control
Tori Rodriguez, MA, LPC, AHC According to global estimates, asthma affects more than 300 million people of all ages, and one-half of asthma patients have poor disease control despite the…